Indoor Radon Concentration and Risk Estimation: the EURA PROJECT

The indoor radon concentration level has been monitored in selected locations in four European countries (Iceland, Italy, Norway, and Sweden) during a yearlong measurement campaign using time-integrated passive radon dosimeters containing CR-39 track detectors. The measurements were carried out in p...

Full description

Saved in:
Bibliographic Details
Published inJournal of Human, Earth, and Future Vol. 2; no. 4; pp. 323 - 333
Main Authors Barca, D., Bjosvik, L. Liguori, Edman, G., Eliasson, U. H., Gervino, G., Philemark, C., Due Svendson, B. E.
Format Journal Article
LanguageEnglish
Published Ital Publication 01.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The indoor radon concentration level has been monitored in selected locations in four European countries (Iceland, Italy, Norway, and Sweden) during a yearlong measurement campaign using time-integrated passive radon dosimeters containing CR-39 track detectors. The measurements were carried out in private houses and public buildings like schools, for an exposure time of up to 6 months for each detector. Experimental data shows a great variation between different geographic areas, and often the average levels are over the acceptable radon limit of 300 Bq/m3recommended by the International Commission on Radiological Protection (ICRP). To investigate a relationship between indoor radon exposure and lung cancer, estimating the cumulative levels of exposure to indoor radon for an individual or population is necessary. We analyse the data sets and investigate the factors influencing indoor radon concentrations in order to determine the best use of the experimental information. The results show that the variables associated with indoor radon levels are strictly linked to the soil geology. Analyzing the data sets enables improved assessment of radon exposure in a given area. The average absorption effective dose equivalent for a person is computed, and the risk of lung cancer per year is evaluated. Doi: 10.28991/HEF-2021-02-04-01 Full Text: PDF
ISSN:2785-2997
2785-2997
DOI:10.28991/HEF-2021-02-04-01